Cannabis stock Cannapharmarx Inc is higher by 11.2% Thursday. Cannapharmarx Inc (CPMD) is near the bottom in its industry group according to InvestorsObserver. CPMD gets an overall rating of 7. That means it scores higher than 7 percent of stocks. Cannapharmarx Inc gets a 8 rank in the Drug Manufacturers – Specialty & Generic industry. Drug Manufacturers – Specialty & Generic is number 142 out of 148 industries.
What do These Ratings Mean?
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What’s Happening With Cannapharmarx Inc Stock Today?
Cannapharmarx Inc (CPMD) stock is flat 11.2% while the S&P 500 has fallen -1.31% as of 11:44 AM on Thursday, Feb 17. CPMD is flat $0.00 from the previous closing price of $0.02 on volume of 355,846 shares. Over the past year the S&P 500 is up 12.34% while CPMD has fallen -93.75%. CPMD lost -$0.35 per share the over the last 12 months.
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.